PMID: 6401797Feb 1, 1983Paper

Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor

The Journal of Experimental Medicine
A MuraguchiA S Fauci

Abstract

The present study demonstrates the minimal, optimal, and synergistic signals involved in the activation of normal human peripheral blood and tonsillar B cells to proliferation. Initial activation signals were delivered to B cells by low concentrations of anti-mu antibody which did not induce proliferation by themselves. However, marked synergy was seen when anti-mu antibody was added to cultures in the presence of monoclonal B cell growth factor (BCGF) obtained from a human T-T cell hybrid such that the B cells underwent substantial proliferation. This latter proliferation was seen without maturation into Ig-secreting cells, which indicates that the BCGF is not a differentiation signal but a signal that drives the cell up to but not beyond the proliferative phase. Of note was the fact that B cells reflected differential sensitivity on the basis of size to either the activation signal delivered by anti-mu antibody or the proliferative signal delivered by BCGF. BCGF directly stimulated the larger B cells in the normal tonsillar B cell repertoire to proliferate without the requirement for an in vitro activation signal, which indicates that the cells had already received some form of activation signal in vivo. Indeed, these cells e...Continue Reading

References

Dec 1, 1979·The Journal of Experimental Medicine·J Watson
Jul 14, 1977·Nature·S Gillis, K A Smith
Jan 1, 1979·The Journal of Experimental Medicine·P E BakerK A Smith
Mar 1, 1978·The Journal of Experimental Medicine·D G SieckmannW E Paul
Jan 1, 1983·The Journal of Experimental Medicine·J L ButlerA S Fauci
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S Gillis, S B Mizel
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J Anderson, F Melchers
Sep 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M HowardW E Paul
May 1, 1982·The Journal of Experimental Medicine·A L DefrancoW E Paul
Jan 1, 1982·Immunological Reviews·A L DeFrancoW E Paul
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·B SredniA S Fauci
Nov 1, 1981·The Journal of Experimental Medicine·B SredniW E Paul
Mar 1, 1982·The Journal of Experimental Medicine·M HowardW E Paul
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C A Whitlock, O N Witte

❮ Previous
Next ❯

Citations

Sep 1, 1992·Cancer Metastasis Reviews·N J McCarthyG T Williams
Jul 1, 1987·Journal of Clinical Immunology·T MiyawakiM D Cooper
Jul 1, 1990·Journal of Clinical Immunology·J P CoutelierB S Prabhakar
Oct 24, 1985·Journal of Immunological Methods·A J GearingR Thorpe
Jun 10, 1986·Journal of Immunological Methods·H AbeJ J Oppenheim
Jun 26, 1987·Journal of Immunological Methods·R J Warrington
Sep 13, 1988·Journal of Immunological Methods·J Bauer, K Hannig
Aug 1, 1984·Parasitology·N A Mitchison
Jul 26, 1984·The New England Journal of Medicine·F S RosenR J Wedgwood
Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A L MaizelC G Sahasrabuddhe
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·L LeclercqJ Thèze
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·C G SahasrabuddheA Maizel
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J L ButlerA S Fauci
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L ChatenoudJ F Delfraissy
Jan 1, 1983·Transactions of the Association of American Physicians·J H Kehrl, A S Fauci
Sep 1, 1983·The Journal of Experimental Medicine·A MuraguchiA S Fauci
Sep 1, 1984·The Journal of Experimental Medicine·N W RoehmJ C Cambier
Oct 1, 1984·The Journal of Experimental Medicine·R H ZublerH R MacDonald
May 1, 1985·The Journal of Experimental Medicine·O LantzJ C Brouet
Oct 1, 1985·The Journal of Experimental Medicine·S M RudichP K Mongini
Nov 1, 1986·The Journal of Experimental Medicine·M K CrowS M Friedman
Feb 1, 1988·The Journal of Experimental Medicine·A MuraguchiT Kishimoto
Oct 1, 1988·The Journal of Experimental Medicine·M G PetersE J Brown
Jan 15, 1986·European Journal of Biochemistry·M D'IncalciW M Bonner
Feb 1, 1985·The Journal of Clinical Investigation·J L Ambrus, A S Fauci
Feb 1, 1985·The Journal of Clinical Investigation·T R CuppsA S Fauci
Nov 1, 1989·The Journal of Clinical Investigation·E K ChartashS M Friedman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved